Can, N.Ö.; Çevik, U.A.; Sağlık, B.N.; Özkay, Y.; Atlı, Ö.; Baysal, M.; Özkay, Ü.D.; Can, Ö.D.
Pharmacological and Toxicological Screening of Novel Benzimidazole-Morpholine Derivatives as Dual-Acting Inhibitors. Molecules 2017, 22, 1374.
https://doi.org/10.3390/molecules22081374
AMA Style
Can NÖ, Çevik UA, Sağlık BN, Özkay Y, Atlı Ö, Baysal M, Özkay ÜD, Can ÖD.
Pharmacological and Toxicological Screening of Novel Benzimidazole-Morpholine Derivatives as Dual-Acting Inhibitors. Molecules. 2017; 22(8):1374.
https://doi.org/10.3390/molecules22081374
Chicago/Turabian Style
Can, Nafiz Öncü, Ulviye Acar Çevik, Begüm Nurpelin Sağlık, Yusuf Özkay, Özlem Atlı, Merve Baysal, Ümide Demir Özkay, and Özgür Devrim Can.
2017. "Pharmacological and Toxicological Screening of Novel Benzimidazole-Morpholine Derivatives as Dual-Acting Inhibitors" Molecules 22, no. 8: 1374.
https://doi.org/10.3390/molecules22081374
APA Style
Can, N. Ö., Çevik, U. A., Sağlık, B. N., Özkay, Y., Atlı, Ö., Baysal, M., Özkay, Ü. D., & Can, Ö. D.
(2017). Pharmacological and Toxicological Screening of Novel Benzimidazole-Morpholine Derivatives as Dual-Acting Inhibitors. Molecules, 22(8), 1374.
https://doi.org/10.3390/molecules22081374